AVITA Medical (RCEL) Net Cash Flow (2019 - 2025)

AVITA Medical (RCEL) has 7 years of Net Cash Flow data on file, last reported at -$5.2 million in Q4 2025.

• For the quarter ending Q4 2025, Net Cash Flow fell 12.86% year-over-year to -$5.2 million; the trailing twelve-month figure through Dec 2025 stood at -$3.8 million (up 52.81% YoY), and the FY2025 full-year result was -$3.8 million, up 52.81% from the prior year.
• Net Cash Flow for Q4 2025 stood at -$5.2 million, down from $3.2 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $55.1 million in Q1 2021 and bottomed at -$64.0 million in Q2 2022.
• The 5-year median for Net Cash Flow is -$3.6 million (2024), against an average of -$7.3 million.
• The widest annual swing landed in 2021, when Net Cash Flow jumped 822.38%; it then slumped 629.74% in 2025.
• A 5-year view of Net Cash Flow shows it stood at -$50.2 million in 2021, then surged by 88.66% to -$5.7 million in 2022, then slumped by 404.57% to -$28.7 million in 2023, then jumped by 84.03% to -$4.6 million in 2024, then declined by 12.86% to -$5.2 million in 2025.
• The last three Net Cash Flow figures came in at -$5.2 million (Q4 2025), $3.2 million (Q3 2025), and -$2.7 million (Q2 2025), per Business Quant data.

Peer Comparison